beta Synuclein Antikörper
-
- Target Alle beta Synuclein (SNCB) Antikörper anzeigen
- beta Synuclein (SNCB) (Synuclein, beta (SNCB))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser beta Synuclein Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- synuclein, beta
- Isotyp
- IgG
- Top Product
- Discover our top product SNCB Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:1000, IP: 1:500-1:1000, IHC: 1:10-1:100, IF: 1:10-1:100
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
- Target
- beta Synuclein (SNCB) (Synuclein, beta (SNCB))
- Andere Bezeichnung
- SNCB (SNCB Produkte)
- Hintergrund
- Synonyms:Beta synuclein, SNCB, synuclein, beta, SYUB Background:Non-amyloid component of senile plaques found in Alzheimer disease. Could act as a regulator of SNCA aggregation process. Protects neurons from staurosporine and 6-hydroxy dopamine(6OHDA)-stimulated caspase activation in a p53/TP53-dependent manner. Contributes to restore the SNCA anti-apoptotic function abolished by 6OHDA. Not found in the Lewy bodies associated with Parkinson disease.
- Molekulargewicht
- 14-18 kDa
- Gen-ID
- 6620
- UniProt
- Q16143
-